📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
26 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 6 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
53
53 articles ont été cités au moins 53fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
9 642
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
649
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
211
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
De Booba à Indexia : ce que les scandales révèlent des angles morts de la recherche en management
2026ArticleRevue Française de Gestion
Long-term evolution of retinal atrophy after focal laser photocoagulation of telangiectatic capillaries: LyoMAC3 study
2025ArticleEye
Effects of dietary camelina oil intake on skeletal muscle metabolism and sarcopenia in older mice
2025ArticleJournal of Physiology and Biochemistry
A transportable laser-plasma accelerator in the MeV range
2025ArticleScientific Reports
Contrainte légale et stratégie des entreprises en matière de compliance
2025Chapitre
Polyunsaturated fatty acids prevent myosteatosis and lipotoxicity
2024ArticleJournal of Nutritional Biochemistry
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Radio-Canada · 29/01/2025
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPRkcyOHdyUHJCV0ZVS1BiN05oR2tfdkpmbU1xZ1dRemR1cXk1cHpMdWlCMjRxLXdtTzBRaGtIRXFUdW4wUnRKb2R0ckNJcXZ4RHpjSG9rM29aNUtDT2E1NjMzYk00cWdxaFlIM1VIZXZSZE5kYmFQMW5wMUVfRjBMOG9PdFYzR0hSUHo1RGpKOA?oc=5" target="_blank">Opération séduction pour l’indust
📰 L'Humanité · 29/09/2023
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNX2owbEpHUjN1X1FWUkthQUxYS1JKb3dMblp2ZnFIN3AtZmgyMDVNYUZvaXdrLTBfUzY2azRmRVN5QXhnbFBNazRuajMtMTAwRnlCMEg4dGtVVzRWQWFRV0cyTFVxYnFaZkpJZUxiSmZwRjE1X2RKWDdqMGFNaEY0UGlDNHFlRF9RT3h1eDlxSTV0a1dFOVZWMklEUUZFZHVWbUhGTlc0a0pCeHJnaTZNcVVVMmFmVS12R2
📰 parismatch.com · 09/06/2022
<a href="https://news.google.com/rss/articles/CBMihAJBVV95cUxPSVFMVEJWTGRDYXpkWmI0NDMxMzBNVlhXdmozR2xBRk5jYjZ2c0x1Umk0UmJ1RkhCRUFFb19pcUE1eWQ5azcybkltYWFEWUVWRVNMOGpoOHVvQTlpc052Mm8zTjBqQWtnNkc5LTExTk5hZXVZVTBEeEJWUHRGWjRCYU9mT0hSTThqVlJPWWxvV25LS1ltZ0hEdmx5SlllN2o5dU1iSTJkQnozZExFTHdQVTJHY0lfQVdrYl
📰 Ouest-France · 10/04/2017
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNVG5HdDk4MHN5SFlhREhtYW5MQUpLUmpid3pqRGFNTWNIM1FPdVBid3pZaVh3bU1ZUHoyd2JRenpCYWFzM2Y4SGVfZUxZMEtaSmdmNDh2dTBsZ3lUWWl2UEVNS1A4T1BsVnY1ZEZBdGkzMkZEUHNPYTFnZ011MXBuaW1HUm1ybFFOZnhoN1JVejloMmVHZzFfU05CYzhiOUZ6YTZxYVMxR0xrTExDZElYVk9XV1JSRmZDUm
📰 Top Santé · 24/04/2013
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNT1pTNEtZSVd0Y1kxUWRBN0dlSzJqbGYzZWNjZ0Y1b0d0WXRXcEFuT3pvb1ZlNzVCcWtUN1Q2STF3XzR6OVBIalF4bGpvMVJSbVFmdzlGZEVyQnVvZzlHZDRVSFVuLWIyU3BkT04yNHItVHRzcFctd3FESUh6cWV3emtheVktRThHY1NhRlpnSEdDX1hyMGc?oc=5" target="_blank">Yeux: quel médecin consu
📰 Ouest-France · 21/01/2010
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQOHh1Nm1wOW1QWTF6dXIxVFdkRGVzZkU3Mmx2Tk5ieEtPSlotd1VnejhMTEluRC1vY2xlb2JuTkFkM0VGV2JSOUJfa0p5ZzlLVmxxQnZseTE0YUJhYW9DWVo3WDR3RkZDOVZLQU11Y3JrM3VsM3hEZ2xsRWgydXF2NnpCSGU3bUxUcWFTRA?oc=5" target="_blank">La liste du parti socialiste est conn
The British journal of ophthalmology · 2022
Background/AimsThe current study evaluates the efficacy and safety of the stand-alone implantation of the MINIject (iSTAR Medical, Wavre, Belgium) supraciliary, microinvasive glaucoma drainage device in patients with medically uncontrolled open-angle glaucoma.MethodsThis prospective, multicentre, first-in-human, single-arm interventional study evaluated stand-alone, ab interno implantation in 25 patients of a 5 mm long uveoscleral device made of STAR biocompatible material, which is a soft, microporous, flexible silicone. The primary outcome was the reduction of intraocular pressure (IOP) at 6 months compared with baseline, and follow-up continued until 2 years for 21 patients. Secondary outcomes included success defined as diurnal IOP of ≤21 mmHg and >5 mmHg with an IOP reduction of 20% without (complete) or with/without (qualified) glaucoma medication.ResultsMean baseline IOP was 23.2±2.9 mmHg on 2.0±1.1 glaucoma medication ingredients and decreased to 13.8±3.5 mmHg (−40.7% reduction) on 1.0±1.3 medications 2 years after implantation. Complete success was achieved in 47.6% of patients (10/21) and qualified success in 100% of patients (21/21) at the 2-year follow-up. All patients achieved a 20% IOP reduction with 48% of patients medication-free. No serious ocular adverse events or additional glaucoma surgery were reported. Mean central endothelial cell density (ECD) mildly decreased from 2411 cells/mm2 (n=26) to 2341 cells/mm2 (n=21) at 24 months, which represents a 5% decrease for matched eyes. No patient had a ≥30% decrease in central ECD.ConclusionThis first-in-human study on the stand-alone implantation of the MINIject supraciliary drainage system shows promising IOP-lowering results and medication reduction over 24 months with few adverse events.Trial registration numberNCT03193736.
Retina (Philadelphia, Pa.) · 2021
Purpose: To analyze the incidence, risk factors, and time to onset of ocular hypertension (OHT) after intravitreal injections (IVI) of dexamethasone implant and to evaluate the long-term cumulative probability of intraocular pressure elevation. Methods: Eyes of patients having received at least one dexamethasone implant IVI between October 2010 and February 2015 were included in the present study. Ocular hypertension was defined as intraocular pressure > 25 mmHg and/or an increase of 10 mmHg over the follow-up period compared with baseline intraocular pressure. Results: Four hundred ninety-four eyes were studied in 410 patients. For a total of 1,371 IVI, the incidence of OHT was 32.6% in the study eyes with a mean follow-up period of 30 months (3–62.5) and a median follow-up of 29 months. Pressure-lowering treatment was introduced for 36.9% of eyes. Topical treatment alone was sufficient to manage OHT in 97%. Young age, male sex, uveitis and retinal vein occlusion, and glaucoma treated with a double- or triple-combination topical pressure-lowering medication were found to be risk factors for OHT. The incidence of OHT did not change with an increase in the number of IVI, and there was no cumulative effect, defining by an increase of the incidence of OHT in patients after repeated IVI (P = 0.248). Conclusion: This study confirmed that OHT is of moderate incidence, transient, controlled by topical treatment and provides data on the long-term cumulative probability of intraocular pressure elevation in a large cohort of eyes treated with dexamethasone implant IVI. Repeat injections of dexamethasone implant neither increase nor decrease the risk of OHT.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
BMC ophthalmology · 2026 · Journal Article
Al-Hamoud D, Jacquot R, Richard-Colmant G, Gerfaud-Valentin M, et al.
Ophthalmology. Retina · 2024 · Journal Article
Chacun S, Kodjikian L, Ricard C, Elbany S, et al.
International journal of ophthalmology · 2023 · Journal Article
Sejournet L, Kodjikian L, Rezkallah A, Denis P, et al.
Journal of clinical medicine · 2023 · Journal Article
Ferracci D, Mathis T, Gavoille A, Gerfaud-Valentin M, et al.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2023 · Journal Article
Kodaday K, Kodjikian L, Gadiollet E, Chirpaz N, et al.
European journal of ophthalmology · 2022 · Journal Article
Mathis T, Mouchel R, Malecaze J, Garcin T, et al.
Journal of clinical medicine · 2022 · Journal Article
Kielwasser G, Kodjikian L, Dot C, Burillon C, et al.
Journal of clinical medicine · 2022 · Journal Article
Rezkallah A, Douma I, Bonjour M, Mathis T, et al.
Ocular immunology and inflammation · 2022 · Journal Article
Chirpaz NM, Kerever SMP, Gavoille AM, Kodjikian LMP, et al.
The British journal of ophthalmology · 2022 · Clinical Trial
Denis P, Hirneiß C, Durr GM, Reddy KP, et al.
International journal of ophthalmology · 2021 · Journal Article
Leroux P, Rezkallah A, Kodjikian L, Loria O, et al.
Advances in therapy · 2021 · Journal Article
Harasymowycz P, Hutnik C, Rouland JF, Negrete FJM, et al.
Journal of clinical medicine · 2021 · Journal Article
Mathis T, Dimassi S, Loria O, Sudhalkar A, et al.
Pharmaceutics · 2021 · Journal Article
Pinto M, Mathis T, Massin P, Akesbi J, et al.
Journal of ophthalmic inflammation and infection · 2025 · Journal Article
Alyami A, Vermot-Desroches V, Serrar Y, Denis P
European journal of ophthalmology · 2023 · Case Reports
Serrar Y, Rezkallah A, Kodjikian L, Poli M, et al.
Case reports in ophthalmology · 2022 · Case Reports
Rezkallah A, Loria O, Mathis T, Chacun S, et al.
Ophthalmology and therapy · 2026 · Journal Article
Serrar Y, Sejournet L, Allignet B, Bounetta S, et al.
Current medical research and opinion · 2024 · Journal Article
Cordeiro MF, Denis P, Astarita C, Belsey J, et al.
Retina (Philadelphia, Pa.) · 2021 · Journal Article
Rezkallah A, Mathis T, Abukhashabah A, Voirin N, et al.
Pharmaceutics · 2024 · Journal Article
Sejournet L, Mathis T, Vermot-Desroches V, Serra R, et al.
American journal of ophthalmology · 2024 · Meta-Analysis
Dick HB, Mackert MJ, Ahmed IIK, Denis P, et al.
Pharmaceutics · 2023 · Journal Article
Séjournet L, Kodjikian L, Elbany S, Allignet B, et al.
Journal of glaucoma · 2021 · Journal Article
Aptel F, Villemont AS, Cunnac P, Sallit R, et al.
Journal francais d'ophtalmologie · 2023 · Journal Article
Rodier-Bonifas C, Rochet E, Seve P, Duquesne A, et al.
American journal of ophthalmology · 2024 · Meta-Analysis
Dick HB, Mackert MJ, Ahmed IIK, Denis P, et al.
Journal of ophthalmic inflammation and infection · 2025 · Journal Article
Alyami A, Vermot-Desroches V, Serrar Y, Denis P
European journal of ophthalmology · 2021 · Journal Article
Denis P, Duch S, Chen E, Klyve P, et al.
Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
<b>Article full text</b> <br> The full text of this article can be found here<b>.</b> https://link.springer.com/article/10.1007/s40123-016-0052-8?view=classic <br> <b>Provide enhanced content for this article</b> <br> If
Incidence of Irvine Gass Syndrome after Phacoemulsification with Spectral-Domain Optical Coherence Tomography
<i>Purpose</i>: Incidence of significant and non-significant macular edema found using spectral-domain optical coherence tomography (SD-OCT) following cataract surgery. <i>Methods</i>: Prospective, cohort series conducte
Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options
Full copyright for enhanced digital features is owned by the authors. <strong>Article full text</strong> <br> The full text of this article can be found <b>here</b>. <br> <br> <strong>Provide enhanced digital features fo
Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ©) in glaucoma using a qualitative study
Abstract Background Compliance is a major issue in glaucoma care. It is usually poor in glaucomatous patients, and may ultimately result in an acceleration of the disease progression and a risk of blindness. Reasons for
Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
<b>Article full text</b> <br> The full text of this article can be found here<b>.</b> https://link.springer.com/article/10.1007/s40123-016-0052-8?view=classic <br> <b>Provide enhanced content for this article</b> <br> If
Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
<b>Article full text</b> <br> The full text of this article can be found here<b>.</b> https://link.springer.com/article/10.1007/s40123-016-0052-8?view=classic <br> <b>Provide enhanced content for this article</b> <br> If
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).